Stem cell exhaustion due to Runx1 deficiency is prevented by Evi5 activation in leukemogenesis

Blood. 2010 Feb 25;115(8):1610-20. doi: 10.1182/blood-2009-07-232249. Epub 2009 Dec 14.

Abstract

The RUNX1/AML1 gene is the most frequently mutated gene in human leukemia. Conditional deletion of Runx1 in adult mice results in an increase of hematopoietic stem cells (HSCs), which serve as target cells for leukemia; however, Runx1(-/-) mice do not develop spontaneous leukemia. Here we show that maintenance of Runx1(-/-) HSCs is compromised, progressively resulting in HSC exhaustion. In leukemia development, the stem cell exhaustion was rescued by additional genetic changes. Retroviral insertional mutagenesis revealed Evi5 activation as a cooperating genetic alteration and EVI5 overexpression indeed prevented Runx1(-/-) HSC exhaustion in mice. Moreover, EVI5 was frequently overexpressed in human RUNX1-related leukemias. These results provide insights into the mechanism for maintenance of pre-leukemic stem cells and may provide a novel direction for therapeutic applications.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Cell Cycle Proteins
  • Cell Transformation, Neoplastic / genetics
  • Cell Transformation, Neoplastic / metabolism*
  • Cell Transformation, Neoplastic / pathology
  • Core Binding Factor Alpha 2 Subunit*
  • GTPase-Activating Proteins
  • Hematopoietic Stem Cells / metabolism*
  • Hematopoietic Stem Cells / pathology
  • Humans
  • Leukemia / genetics
  • Leukemia / metabolism*
  • Leukemia / pathology
  • Mice
  • Mice, Knockout
  • Nuclear Proteins*
  • Transcription Factors*

Substances

  • Cell Cycle Proteins
  • Core Binding Factor Alpha 2 Subunit
  • EVI5 protein, human
  • Evi5 protein, mouse
  • GTPase-Activating Proteins
  • Nuclear Proteins
  • RUNX1 protein, human
  • Runx1 protein, mouse
  • Transcription Factors